JPRN-UMIN000010978已完成未知
Efficacy of switching to 0.1% Brimonidine Tartrate in glaucoma patients under combined theraphy. - Efficacy of switching to 0.1% Brimonidine Tartrate.
Department of Ophthalmology, Yamagata University Medical Hospital.0 个研究点目标入组 32 人开始时间: 2013年6月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Glaucoma patient that it is determined effect is sufficient clinically in the treatment of current.
研究者
相似试验
已完成
不适用
Efficacy, tolerability and safety of 0.2% Brimonidine-Tartrate for the treatment of acute non-arteritic anterior ischaemic optic neuropathyEye Diseases: Non-arteritic anterior ischemic optic neuropathyEye DiseasesOther disorders of optic [2nd] nerve and visual pathwaysISRCTN72549635Department of Health (UK)
招募中
3 期
Effect of brimonidine tartrate gel 0.33% versus tretinoin cream 0.05% on post-acne erythemaAcne.AcneIRCT20120215009014N490Hamedan University of Medical Sciences90
进行中（未招募）
1 期
Patient feedback of persistent facial rednessErythema of rosaceaMedDRA version: 20.0 Level: PT Classification code 10039218 Term: Rosacea System Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2012-005686-12-GBGalderma R&D80
进行中（未招募）
不适用
Patient feedback on the treatment of their persistent facial rednessEUCTR2012-005686-12-SEGalderma R&D80
进行中（未招募）
不适用
Patient feedback on the treatment of their persistent facial rednessEUCTR2012-005686-12-DEGalderma R&D80